Creatinine test reagent
By screening gene sequences of enzymes for creatinine detection tools in the NCBI gene bank, constructing recombinant expression engineered bacteria and optimizing fermentation conditions, the problem of high cost of enzymatic creatinine detection was solved, realizing the industrial production and efficient detection of domestically produced creatinine detection reagents.
Patent Information
- Application Number
- CN202410589054.X
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2024-05-13
- Publication Date
- 2026-11-17
- Estimated Expiration
- 2044-05-13
AI Technical Summary
The high price of enzymes for creatinine detection in China leads to high testing costs, hindering the application of enzymatic methods for creatinine determination in the country. Furthermore, there is a lack of highly active and stable enzymes for creatinine detection.
By screening gene sequences of enzymes for creatinine detection tools in the NCBI gene library, constructing recombinant expression engineered bacteria, optimizing fermentation and induction conditions, increasing the expression levels of creatinine enzyme, creatine oxidase, and creatine oxidase, and purifying them for industrial production.
This has reduced the production cost of enzymes for creatinine detection, provided domestically produced creatinine detection reagents with a detection limit of 90.75 μM, superior detection performance compared to commercially available reagent kits, and good accuracy, laying the foundation for domestically produced enzyme preparations for in vitro diagnostic creatinine.
Smart Images

Figure CN118620876B_ABST
Abstract
Description
Technical Field
[0001] This invention relates to reagents for detecting creatinine. Background Technology
[0002] With social development and accelerated urbanization, people's work and life pace has gradually accelerated. Lack of exercise and insufficient sleep can lead to an increased incidence of kidney disease. Early and accurate diagnosis of kidney disease is crucial for patient treatment. The measurement of creatinine in serum and urine provides objective indicators for clinical evaluation of glomerular filtration function, and creatinine testing is also one of the main items in routine blood tests. Creatinine-degrading enzyme-based detection of creatinine has the characteristics of strong anti-interference ability, good specificity, wide linear range, high sensitivity, and simple operation. Some research has been conducted on enzymatic detection of creatinine both domestically and internationally, and creatinine detection kits have been successfully developed and are gradually being used in clinical diagnosis. Creatininase (CA, EC 3.5.2.10), creatinase (CI, EC 3.5.3.3), and sarcosine oxidase (SOX, EC 1.5.3.1) are key enzymes used in enzymatic detection of creatinine. Enzymatic creatinine detection requires high purity and stability of the enzymes. Currently, China cannot industrially produce enzymes for creatinine detection, relying heavily on imports. The high price of these enzymes severely hinders their application in China. Therefore, researching the production of highly active and stable enzymes for creatinine detection is of significant importance for controlling testing costs, reducing the burden on patients, and enabling the widespread application of enzymatic creatinine determination. Summary of the Invention
[0003] To address the problems existing in the prior art, this invention provides a creatinine detection reagent. Creatininase (CA, EC 3.5.2.10), creatinase (CI, EC 3.5.3.3), and sarcosine oxidase (SOX, EC 1.5.3.1) are key enzymes for enzymatic detection of creatinine. This invention obtained the gene or protein sequences of these three creatinine detection enzymes by screening from the NCBI gene library, constructed recombinant expression engineered bacteria for each, induced enzyme production, and improved expression levels by optimizing fermentation and induction conditions. The enzymatic properties of the three enzymes were also studied, providing a theoretical basis for reducing the production cost of creatininase, creatinine oxidase, and sarcosine oxidase and realizing industrial production. Fermentation conditions were studied, and the three enzymes were scaled up for production in a 5L fermenter to obtain large-scale industrial-grade enzymes. The performance of the three-enzyme cascade for creatinine detection was also verified.
[0004] This invention provides a creatinine detection reagent, which includes recombinant creatinine enzyme, recombinant creatine oxidase and recombinant sarcosine oxidase;
[0005] The amino acid sequence of the recombinant creatinine enzyme is SEQ ID NO.2 in the sequence listing; the amino acid sequence of the recombinant creatine enzyme is SEQ ID NO.4 in the sequence listing; and the amino acid sequence of the recombinant sarcosine oxidase is SEQ ID NO.6 in the sequence listing.
[0006] Preferably, the nucleotide sequence of the recombinant creatinine enzyme is SEQ ID NO.1 in the sequence listing; the nucleotide sequence of the recombinant creatine enzyme is SEQ ID NO.3 in the sequence listing; and the nucleotide sequence of the recombinant sarcosine oxidase is SEQ ID NO.5 in the sequence listing.
[0007] Preferably, the preparation method of the recombinant creatinine enzyme, recombinant creatine oxidase, and recombinant sarcosine oxidase is as follows:
[0008] (1) SEQ ID NO.1, SEQ ID NO.3 and SEQ ID NO.5 in the sequence listing were respectively constructed into a plasmid vector to obtain three recombinant plasmids;
[0009] (2) Three recombinant plasmids were transformed into competent Escherichia coli cells to obtain three recombinant Escherichia coli. Recombinant protein expression was induced in each cell, and the cells were broken up and the supernatant was collected. The supernatant was fermented and cultured to obtain crude enzyme solutions of recombinant creatinine enzyme, recombinant creatine enzyme and recombinant sarcosine oxidase, respectively.
[0010] (3) The three crude enzyme solutions were purified to obtain recombinant creatinine enzyme, recombinant creatine enzyme and recombinant sarcosine oxidase.
[0011] Preferably, in step (2), the fermentation culture method of the recombinant creatinine enzyme is as follows: the supernatant of the recombinant creatinine enzyme is inoculated into the culture medium, the IPTG concentration is 0.2 mmol / L, the inoculation amount is 4%, the dissolved oxygen value is controlled at 30%, and the fermentation culture is induced at 25°C for 18 h.
[0012] The culture medium formula is as follows: glucose 10.30 g / L, yeast extract 21.80 g / L, phosphate 137.60 mmol / L, and tryptone 15.60 g / L.
[0013] Preferably, in step (2), the fermentation culture method of the recombinant creatine enzyme is as follows: the supernatant of the recombinant creatine enzyme is inoculated into the culture medium, and IPTG is added after 4 hours of inoculation. The final concentration of IPTG is 0.4 mmol / L, the inoculation amount is 4%, the dissolved oxygen value is controlled at 35%, and fermentation culture is induced at 30°C for 20 hours.
[0014] The culture medium is TB medium.
[0015] Preferably, in step (2), the fermentation culture method of the recombinant sarcosine oxidase is as follows: the supernatant of the recombinant sarcosine oxidase is inoculated into the culture medium, and IPTG is added after 5 h of inoculation. The final concentration of IPTG is 0.6 mmol / L, the inoculation amount is 6%, the dissolved oxygen value is controlled at 30%, and fermentation culture is induced at 25℃ for 21 h.
[0016] The culture medium is TB medium.
[0017] Preferably, in step (3), the purification method of the recombinant creatinine enzyme, recombinant creatine oxidase and recombinant creatine oxidase is as follows: filter the crude enzyme solution, load the filtrate onto a HisTrap HP affinity column, wash the affinity column with 4% elution buffer until the baseline approaches 0, then elute the recombinant protein with 60% elution buffer, and finally desalt the eluent using a desalting column to obtain the purified recombinant creatinine enzyme.
[0018] Preferably, the ratio of the recombinant creatinine enzyme, recombinant creatine oxidase and recombinant sarcosine oxidase is 1:3:3.
[0019] Preferably, the creatinine detection reagent further includes a chromogen, wherein the chromogen is 0.4 mmol / L of 3-hydroxy-2,4,6-triiodobenzoic acid; and / or
[0020] The creatinine detection reagent further includes a composite protective agent composed of sucrose, sorbitol, Tween 20, and glycerol, wherein the concentrations of sucrose, sorbitol, Tween 20, and glycerol in the creatinine detection reagent are 2.0 g / L, 1.5 g / L, 0.5 g / L, and 2.0 g / L, respectively; and / or
[0021] The creatinine test reagent also includes a preservative, which is potassium sorbate, and the concentration of potassium sorbate in the creatinine test reagent is 1.0 g / L.
[0022] The present invention also provides the application of the above-described creatinine detection reagent in the preparation of creatinine detection kits.
[0023] The creatinine detection reagent of the present invention has a detection limit of 90.75 μM. Compared with the detection performance of commercially available creatinine detection kits, the relative error within the detection range is better than that of commercially available kits, and the accuracy is better. This lays the foundation for the development of domestically produced enzyme preparations for in vitro diagnostic creatinine. Attached Figure Description
[0024] The accompanying drawings are provided to further illustrate the invention and form part of the specification. They are used in conjunction with embodiments of the invention to explain the invention and do not constitute a limitation thereof. In the drawings:
[0025] Figure 1 Construct the CA phylogenetic tree.
[0026] Figure 2 Figure a shows the electrophoresis diagram of recombinant plasmid pET28a His-CA after enzyme digestion. In the figure, M: Marker; 1: plasmid pET-28a His-CA; 2: plasmid double-digested with NcoⅠ and XhoⅠ. Figure b shows the SDS-PAGE analysis of CA after induced expression. In the figure, M: protein standard band; 1: crude CA enzyme solution; 2: whole-cell CA; 3: empty plasmid vector.
[0027] Figure 3 The effect of temperature on the activity (a) and stability (b) of CA.
[0028] Figure 4 The effect of pH on CA activity (a) and stability (b).
[0029] Figure 5 The effects of carbon source type (a) and glucose concentration (b) on fermentation.
[0030] Figure 6 The effects of nitrogen source type (a), yeast extract concentration (b), and tryptone concentration (c) on fermentation.
[0031] Figure 7 The effect of phosphate concentration on fermentation.
[0032] Figure 8 The diagram shows the response surface plots of the interactive effects. It includes the effects of glucose and yeast extract concentrations (a), glucose and phosphate concentrations (b), glucose and tryptone concentrations (c), yeast extract and phosphate concentrations (d), yeast extract and tryptone concentrations (e), and phosphate and tryptone concentrations (f) on CA enzyme activity.
[0033] Figure 9 The effects of CA fermentation induction conditions on enzyme activity are shown in Figure a. Figure a shows the effect of IPTG concentration on fermentation; Figure b shows the effect of inoculum size on fermentation; Figure c shows the effect of fermentation temperature and time on fermentation; and Figure d shows the effect of dissolved oxygen concentration on fermentation. In Figures c and d, hollow icons represent OD values, and solid icons represent enzyme activity.
[0034] Figure 10 SDS-PAGE analysis of the purification results of recombinant creatinine enzyme CA. Wherein, M: Marker; 1: crude CA enzyme solution before purification; 2: CA enzyme solution after purification.
[0035] Figure 11Electrophoresis images of recombinant plasmids pET28a His-CI (a) and pET28a His-SOX (b) after enzyme digestion. In the images, M: Marker; 1: plasmid pET-28a His-CI; 2: plasmid pET-28aHis-CI double-digested with NcoⅠ and XhoⅠ; 3: plasmid pET-28aHis-SOX; 4: plasmid pET-28aHis-SOX double-digested with NcoⅠ and XhoⅠ.
[0036] Figure 12 SDS-PAGE analysis of CI(a) and SOX(b) after induced expression. Wherein, M: protein standard band, 1 is crude CI enzyme solution, and 2 and 3 are crude SOX enzyme solutions.
[0037] Figure 13 The effect of temperature on the activities of CI(a) and SOX(b) enzymes.
[0038] Figure 14 For the thermal stability of CI and SOX.
[0039] Figure 15 The effect of pH on the activities of CI(a) and SOX(b).
[0040] Figure 16 pH stability of CI(a) and SOX(b).
[0041] Figure 17 The growth curves are for the recombinant strains CI(a) and SOX(b).
[0042] Figure 18 The effects of different fermentation induction times on recombinant strains CI(a) and SOX(b).
[0043] Figure 19 The effects of different inducer concentrations and temperatures on the growth and enzyme activity of recombinant bacteria CI(a) and SOX(b).
[0044] Figure 20 The effect of different inoculum amounts on recombinant strains CI(a) and SOX(b).
[0045] Figure 21 The effect of dissolved oxygen in the fermenter on recombinant bacteria CI(a) and SOX(b).
[0046] Figure 22 SDS-PAGE analysis of the purified recombinant creatine oxidase CI (a) and recombinant sarcosine oxidase SOX (b). Wherein, M: Marker; 1: crude CI enzyme solution before purification; 2: CI enzyme solution after purification; 3, 4: crude SOX enzyme solution before purification; 5: SOX enzyme solution after purification.
[0047] Figure 23 To optimize the ratio of two enzymes (a) and three enzymes (b) in the enzymatic cascade system.
[0048] Figure 24 The time-varying absorbance curves of high-concentration creatinine (a, 1.0-8.0 mol / L) and low-concentration creatinine (b, 0.2-0.8 mol / L) with TOOS as the chromatograph are shown.
[0049] Figure 25 Calibration curves for high creatinine concentration (a) and low creatinine concentration (b) using TOOS as the chromogen.
[0050] Figure 26 This is due to the influence of chromogen concentration.
[0051] Figure 27 The time progression curve (a) and calibration curve (b) for the accumulation of 3-hydroxy-2,4,6-triiodobenzoic acid.
[0052] Figure 28 The effects of protective agents on the residual enzyme activity of the system are shown in Figure a. Figure a shows the effect of sugar alcohols on the residual enzyme activity of the system; Figure b shows the effect of organic solvents and nonionic surfactants on the residual enzyme activity of the system.
[0053] Figure 29 The effect of different concentrations of four stabilizers on the residual enzyme activity.
[0054] Figure 30 The effects of a composite protective agent and a preservative on the storage stability of the system at 4°C are shown. In this diagram, a represents the effect of adding the composite protective agent on the storage stability of the system, and b represents the effect of simultaneously adding both the composite protective agent and the preservative on the storage stability of the system. Detailed Implementation
[0055] The following examples are provided to better understand the present invention, but do not limit the invention. Unless otherwise specified, the experimental methods in the following examples are conventional methods. Unless otherwise specified, the experimental materials used in the following examples were purchased from conventional biochemical reagent companies. All quantitative experiments in the following examples were performed in triplicate, and the results were averaged. Example 1: Study on heterologous expression and fermentation optimization of creatinine enzyme CA.
[0056] 1. Experimental Materials and Methods
[0057] 1.1 Culture medium and buffer
[0058] LB liquid medium: 10g tryptone, 5g yeast extract, 5g sodium chloride, bring the volume to 1L with ultrapure water, and sterilize at 121℃ for 20min.
[0059] TB medium: 12g tryptone, 24g yeast extract, 4mL glycerol (87%), 100mL 10× potassium phosphate buffer (pH 8.0), and diluted to 1L with ultrapure water. Sterilize at 121℃ for 20min. The 10× potassium phosphate buffer (pH 8.0) is formulated as follows: 2.31g KH₂PO₄, 12.54g K₂HPO₄, adjusted to pH 8.0, and diluted to 100mL with ultrapure water.
[0060] Tris-HCl buffer solution (20 mmol / L, pH 8.0): Weigh 1.36 g Tris, add ultrapure water to a final volume of 500 mL, and adjust the pH of the solution to 8.0 with concentrated hydrochloric acid.
[0061] PBS buffer (100 mmol / L, pH 8.0): Weigh 6.80 g KH₂PO₄ and bring the volume to 500 mL with ultrapure water. Weigh 8.90 g K₂HPO₄ and bring the volume to 500 mL with ultrapure water. Mix the two solutions in an appropriate ratio until the pH reaches 8.0.
[0062] Sample loading buffer: 20 mmol / L NaH2PO4, 0.5 M NaCl, adjusted to pH 7.4 with NaOH.
[0063] Elution buffer: 500 mmol / L imidazole, 20 mmol / L NaH2PO4, 0.5 M NaCl, adjusted to pH 7.4 with HCl.
[0064] 1.2 Experimental Methods
[0065] 1.2.1 Construction of recombinant plasmid pET28a His-CA
[0066] First, the gene sequence of CA from *Pseudomonas putida* (Genbank: D45424.1) was obtained by screening the NCBI gene bank. Using *E. coli* BL21(DE3) as the host strain and pET28a as the expression vector, the codons of the CA gene were optimized for the *E. coli* expression system. Subsequently, the codon-optimized CA gene was ligated into the expression vector pET28a at the XhoⅠ and NcoⅠ restriction sites to construct the recombinant plasmid pET28aHis-CA. The gene in the recombinant plasmid pET28aHis-CA has a His-tag at the N-terminus. The constructed recombinant plasmid pET28aHis-CA was introduced into *E. coli* competent cells *E. coli* BL21(DE3), and screening was performed on LB agar plates containing kanamycin. The positive strain *E. coli* BL21(DE3) (pET28aHis-CA) was finally obtained. The whole-genome synthesis of the gene sequence and the screening of positive strains were completed by Genewiz Biotechnology Co., Ltd.
[0067] The nucleotide sequence of CA after codon optimization is as follows (SEQ ID NO.1):
[0068] ATGGGCATGAGCAAAAGCGTGTTTTGTGGGCGAACTGACCTGGAAAGAATATGAAGC
[0069] GCGCGTGGCGGCGGGCGATTGCGTGCTGATGCTGCCGGTGGGCGCGCTGGAACAGC
[0070] ATGGCCATCATATGTGCATGAACGTGGATGTGCTGCTGCCGACCGCGGTGTGCAAAC
[0071] GCGTGGCGGAACGCATTGGCGCGCTGGTGATGCCGGGCCTGCAGTATGGCTATAAAA
[0072] GTCAGCAGAAAAGCGGCGGTGGCAACCATTTTCCGGGCACCACGAGCCTGGATGGC
[0073] GCGACCCTGACCGGCACCGTGCAAGATATTATTCGCGAACTGGCGCGTCATGGCGCG
[0074] CGCCGCCTGGTGCTGATGAACGGCCATTATGAAAACAGCATGTTTATTGTGGAAGGC
[0075] ATTGATCTGGCGCTGCGCGAACTGCGCTATGCGGGCATTCAAGATTTTAAAGTGGTTG
[0076] TGCTGAGCTATTGGGATTTTGTGAAAGATCCGGCGGTGATTCAGCAGCTGTATCCGGA
[0077] AGGCTTTCTGGGCTGGGATATTGAACATGGCGGCGTGTTTGAAACGAGCCTGATGCT
[0078] GGCGCTGTATCCGGATTTAGTGGATCTGGATCGCGTGGTGGATCATCCGCCGGCGACC
[0079] TTTCCGCCGTATGATGTGTTTCCGGTGGATCCGGCGCGCACCCCGGCGCCGGGCACC
[0080] CTGAGCAGCGCGAAAACCGCGAGCCGCGAAAAAGGCGAACTGATTCTGGAAGTGTGCGTGCAAGGCATTGCGGATGCGATTCGCGAAGAATTTCCGCCGACCCTCGAG.
[0081] Accordingly, the amino acid sequence of CA is (Sequence Listing SEQ ID NO.2):
[0082] MGMSKSVFVGELTWKEYEARVAAGDCVLMLPVGALEQHGHHMCMNVDVLLPTAVCKRVAERIGALVMPGLQYGYKSQQKSGGGNHFPGTTSLDGATLTGTVQDIIRELARHGARRLVLMNGHYENSMFIVEGIDLALRELRYAGIQDFKVVVLSYWDFVKDPAVIQQLYPEGFLGWDIEHGGVFETSLMLALYPDLVDLDRVVDHPPATFPPYDVFPVDPARTPAPGTLSSAKTASREKGELILEVCVQGIADAIREEFPPTLE.
[0083] 1.2.2 Plasmid extraction and double enzyme digestion verification of positive strains
[0084] Prepare 10 mL of LB liquid medium containing kanamycin. Pick a positive single colony with an inoculation loop and culture it at 37℃ and 180 rpm for 16 h. Extract the plasmid according to the standard operating procedure of the plasmid extraction kit (TaKaRa MiniBEST Plasmid Purification Kit). Observe the plasmid size by agarose gel electrophoresis. Select the recombinant plasmid and verify it by digesting it with restriction endonucleases NcoⅠ and XhoⅠ at 37℃ for 1.5 h. The product is then compared with the marker by agarose gel electrophoresis. After verification, the successfully constructed positive recombinant strain is purified by streak plating, and 15% glycerol bacteria are prepared and stored in a freezer at -80℃ for later use.
[0085] 1.2.3 Recombinant Expression of CA
[0086] CA strains preserved at -80℃ were streaked on solid LB medium. Single colonies were picked and cultured in 10 mL of LB liquid medium at 37℃ for 18 h to obtain primary seed culture. The primary seed culture was then inoculated into 50 mL of LB liquid medium at a 1% inoculum and cultured at 37℃ for 6 h to obtain secondary seed culture.
[0087] Shake flask culture conditions: Inoculate primary seed at a rate of 1% into 50 mL of TB medium, supplement with kanamycin to a final concentration of 50 μg / mL, and allow to grow to OD. 600 =0.8, add IPTG to a final concentration of 0.2 mmol / L for induction culture, and incubate at 20℃ for 20 h.
[0088] Fermentation tank cultivation conditions: Using the optimized culture medium, secondary seed culture was inoculated into a 5L fermenter at a volume fraction of 1-7%, and 2‰ of defoamer powder was added. The dissolved oxygen value was kept constant at 10-30%. The aeration speed and dissolved oxygen value were set in series, the aeration rate was 6L / min, and the tank temperature was set to 37℃. The fermentation was carried out until the strain reached OD. 600 =1.8, add IPTG for induction culture, so that the final concentration of IPTG in the fermentation broth is 0.05-0.6 mmol / L, and set the temperature in the tank to 20-30℃ to facilitate the expression of CA by the engineered strain. After induction culture for 10-24 h, collect the cells by centrifugation at 4℃ and 8000 r / min for 5 min.
[0089] 1.2.4 Preparation of Crude CA Enzyme Solution
[0090] After the recombinant bacterial fermentation was completed, the fermentation broth was collected and centrifuged at 8000 rpm for 10 min at 4 °C. After centrifugation, the supernatant was discarded and the bacterial pellet was collected. The bacterial pellet was resuspended and washed three times with Tris-HCl buffer (20 mmol / L, pH 8.0), and finally resuspended in 1 / 3 volume of Tris-HCl buffer (20 mmol / L, pH 8.0). Homogenization was performed using a high-pressure homogenizer at 4 °C and 800 kPa, with each 50 mL of bacterial culture being homogenized for 45 s. The resulting cell lysate was centrifuged at 12000 rpm for 20 min at 4 °C. The supernatant obtained was the crude CA enzyme solution, which was stored at 4 °C. CA expression was detected by SDS-PAGE.
[0091] 1.2.5 Determination of CA enzyme activity
[0092] The detection principle of CA activity: The substrate creatinine is hydrolyzed to creatine under the action of CA, which reacts with α-naphthol, which is oxidized by diacetyl under weakly alkaline conditions, to generate α-naphthoquinone, and generates a fluorescent compound. The absorbance of this fluorescent product can be measured at a wavelength of 525 nm.
[0093] (1) Construction of the creatine standard curve
[0094] Prepare creatine solutions of varying concentrations and plot a creatine standard curve.
[0095] (2) Detection of enzyme activity
[0096] Enzyme activity is defined as the amount of CA required per minute to hydrolyze the substrate to produce 1 μmol of creatine in a reaction solution at 37°C, which is one unit of enzyme activity (U).
[0097] Formula for calculating specific enzyme activity:
[0098] Where U: enzyme activity; mg: protein content.
[0099] The enzyme activity per unit volume (mL) of enzyme solution is defined as the enzyme activity per milliliter (U / mL).
[0100] (3) Determination of protein concentration
[0101] The Bradford method was used to determine the protein concentration in the reaction system.
[0102] 1.2.6 Study on the enzymatic properties of CA
[0103] (1) Optimal temperature and thermal stability of CA
[0104] Determination of optimal temperature: Under pH 8.0 conditions, the effect of temperature changes on enzyme activity was determined at temperatures of 20, 30, 40, 50, 60, 70 and 80 °C. The reaction solution with added inactivated enzyme was used as a blank control, and the highest enzyme activity was taken as 100%. The ratio of enzyme activity under other temperature conditions to the highest enzyme activity was used as the relative enzyme activity under that temperature condition.
[0105] Thermal stability test: Under pH 8.0 conditions, take an appropriate amount of enzyme solution and incubate it at 37, 50 and 60℃ respectively. Measure the remaining enzyme activity at different incubation times, with the initial activity as 100%.
[0106] Then, at pH 8.0, take an appropriate amount of enzyme solution, incubate it at 75°C for 30 min, and measure the remaining enzyme activity, with the initial activity as 100%.
[0107] (2) Optimal pH and pH stability of CA
[0108] Optimal pH determination: The enzyme was incubated at 37°C at pH values of 4.0, 5.0, 6.0, 7.0, 8.0, 9.0, and 10.0 to determine the effect of pH changes on enzyme activity. The reaction solution containing inactivated enzyme was added as a blank control. The highest enzyme activity was taken as 100%. The ratio of enzyme activity under other pH conditions to the highest enzyme activity was used as the relative enzyme activity under that pH condition.
[0109] pH stability determination: Appropriate amounts of enzyme solution were placed in buffer solutions at pH 4.0, 5.0, 6.0, 7.0, 8.0, 9.0, and 10.0, respectively, and incubated at 37℃ for 24 h. The residual enzyme activity after treatment under different pH conditions was measured, with the initial activity considered as 100%. 1.2.7 Optimization of CA culture medium composition
[0110] (1) Optimization of carbon source type and concentration: Glycerol, glucose, lactose, sucrose and starch with the same mass concentration (10g / L) were added to 50mL of basal medium (TB medium) as the sole carbon source. The Escherichia coli culture conditions were performed according to 1.2.3. The optimal carbon source was selected based on the results. The optimal carbon source concentration was explored within the range of 2-40g / L.
[0111] (2) Optimization of nitrogen source type and concentration: Urea, NH4NO3, (NH4)2SO4, NH4Cl, tryptone and yeast extract were added to 50 mL of basal medium (TB medium) at the same mass concentration (10 g / L) as the sole nitrogen source. The Escherichia coli culture conditions were performed according to 1.2.3. The optimal nitrogen source was selected based on the results. The optimal nitrogen source concentration was explored within the range of 5-35 g / L.
[0112] (3) Phosphate concentration optimization: After determining the optimal carbon source and the optimal nitrogen source types and concentrations, the phosphate concentration range was set within the range of 40-220 mmol / L to explore the optimal concentration. The phosphate formulation was as follows: a stock solution with a pH of 0.5 and a concentration of 0.5M was prepared using dipotassium hydrogen phosphate and potassium dihydrogen phosphate. Different volumes of the stock solution were added according to different concentration ranges.
[0113] 1.2.8 Box-Behnken Design (BBD) Optimization of Culture Medium and Model Fit Validation
[0114] The effects of each factor and its interaction were evaluated using the Response Surface Methodology (RSM) of the BBD. Design Expert 8.0.6 software was used for data processing to identify the interaction among the four selected variables. Each variable was analyzed at three different levels. The central coding value of the four variables was zero, and CA enzyme activity was used as the response value (see Table 1).
[0115] Table 1. Box-Behnken Experimental Design Factors and Level Coding
[0116]
[0117]
[0118] 1.2.9 Optimization of Fermentation Conditions
[0119] Optimization of the amount of IPTG (isopropyl-β-D-thiogalactoside) added: The fermentation was carried out in a 5L fermenter according to the fermentation conditions in 1.2.3. During the induction expression stage, IPTG was added at final concentrations of 0.05, 0.1, 0.2, 0.3, 0.4, 0.5, and 0.6 mmol / L, respectively. After the fermentation culture was completed, the crude enzyme solution was collected and the CA enzyme activity was measured.
[0120] Inoculation optimization: In a 5L fermenter, different inoculation amounts of 1%, 2%, 3%, 4%, 5%, 6%, and 7% were selected for inoculation. After fermentation, the crude enzyme solution was collected and the CA enzyme activity was measured.
[0121] Optimization of induction temperature and time: Fermentation was carried out in a 5L fermenter at three different induction temperatures of 20℃, 25℃ and 30℃, and the CA enzyme activity of the fermentation broth was measured at regular intervals.
[0122] Optimization of dissolved oxygen (DO) concentration: In a 5L fermenter, the dissolved oxygen levels were controlled at 20%, 30%, and 40% during the fermentation process, and the CA enzyme activity of the fermentation broth was measured at regular intervals.
[0123] 1.2.10 Isolation and purification of CA
[0124] The crude enzyme solution was filtered through a 0.22 μm aqueous fiber membrane to obtain the filtrate for later use. Next, it was used... The purification system was used to purify CA. The purification process included the following steps: First, the HisTrap HP affinity column purification system was pre-equilibrated using loading buffer. Then, the filtrate was loaded onto the HisTrap HP affinity column using the NGC™ chromatography system (Bio-Rad) for protein loading. After protein loading, the affinity column was washed with 4% (v / v) elution buffer until the baseline approached 0 to remove other contaminating proteins. Then, the recombinant protein was eluted with 60% (v / v) elution buffer at a flow rate of 1 mL / min, and the resulting eluent was the purified CA. Finally, the solution was desalted using a HiTrap Desalting column (GE Healthcare) to remove excess imidazole, and the purified enzyme solution was stored at 4°C.
[0125] 2 Results and Discussion
[0126] 2.1CA amino acid sequence alignment
[0127] Using the gene sequence of *Pseudomonas putida* CA (Genbank: D45424.1) as a template sequence, 42 similar sequences were obtained from NCBI using BLAST. DNAMAN software was used to align these sequences, revealing their phylogenetic relationship with the archaea CA. Based on the results, a phylogenetic tree of CA was constructed, as follows: Figure 1 As shown.
[0128] Figure 1 Construct the CA phylogenetic tree.
[0129] 2.2 Plasmid extraction and enzyme digestion verification of CA
[0130] The recombinant plasmid pET28a His-CA was double-digested with NcoI and XhoI, and the results were detected by agarose gel electrophoresis and compared with the marker. (See attached image). Figure 2 -a.
[0131] Depend on Figure 2 -a shows that lane 1 is the complete plasmid, and lane 2 contains two bands generated after double digestion, with sizes of 5221bp and 783bp, respectively. These are the remaining fragment sizes of the pET28a and CA plasmids, proving the successful construction of the pET28aHis-CA recombinant plasmid.
[0132] 2.3 Inducible expression of CA
[0133] After fermentation, SDS-PAGE electrophoresis was performed, and the results are shown below. Figure 2 -b.
[0134] Depend on Figure 2 -b indicates that CA is an intracellular enzyme with a molecular weight of approximately 29 kDa, consistent with relevant literature reports, demonstrating the successful construction of the recombinant strain.
[0135] 2.4 Study on the enzymatic properties of CA
[0136] 2.4.1 Optimal Temperature and Thermal Stability of CA
[0137] To determine the optimal temperature and thermal stability of CA, the activity and thermal stability of CA at different temperatures were investigated. The results are shown in [Figure number missing]. Figure 3 .
[0138] like Figure 3 -a, CA exhibits its maximum relative enzyme activity at 60℃, therefore the optimal temperature for CA is 60℃. For example... Figure 3 As shown in Figure -b, under pH 8.0 conditions, CA exhibits good enzyme stability at 37℃, retaining approximately 80% of its initial enzyme activity after 30 hours of incubation. After 30 hours of incubation at 50℃, it retains 54% of its initial enzyme activity, and even after 30 hours of incubation at 60℃, it retains 43% of its initial enzyme activity. These experimental results indicate that CA possesses good thermal stability.
[0139] After incubating CA at 75°C for 30 minutes, it still retained 65.8% of its initial enzyme activity.
[0140] 2.4.2 Optimal pH and pH stability of CA
[0141] The changes in enzyme activity within different pH ranges (4.0-10.0) at 37℃ are as follows: Figure 4 As shown in -a, the optimal pH for CA is 8.0. The pH stability of CA was also investigated, and the results are as follows: Figure 4 -b, CA is relatively stable at pH 8.0-9.0 and can retain more than 80% of the initial enzyme activity.
[0142] Optimization of fermentation medium composition for 2.5CA
[0143] 2.5.1 Selection of carbon source for culture medium and optimization of dosage
[0144] Different carbon sources were added to 50 mL of TB basal medium. The results are as follows: Figure 5As shown in -a, when lactose is used as the carbon source, although the specific enzyme activity is high, the cell growth is poor, and the total enzyme activity produced in the same batch is far lower than with other carbon sources. When glucose is used as the carbon source, the total enzyme production level is basically the same as that of glycerol. Considering that the cost of glucose is much lower than that of glycerol, glucose is chosen as the carbon source for the culture medium. The effect of glucose concentration on CA enzyme activity is shown in Figure 1. Figure 5 -b, When the glucose concentration is 10 g / L, the CA enzyme activity reaches its highest value of 252.53 U / mL, so 10 g / L glucose is finally selected as the optimal carbon source.
[0145] 2.5.2 Selection of Nitrogen Source and Optimization of Dosage in Culture Medium
[0146] Different nitrogen sources were added to 50 mL of basal culture medium. The results are as follows: Figure 6 As shown.
[0147] Depend on Figure 6 As can be seen from -a, the growth of the bacteria was poor when urea, NH4NO3, (NH4)2SO4, and NH4Cl were used as nitrogen sources. When tryptone and yeast extract were used as nitrogen sources, it was found that the growth rate and CA enzyme activity were significantly better when using organic nitrogen sources than when using inorganic nitrogen sources, and yeast extract was superior to tryptone. This is because yeast extract contains various vitamins, growth factors, and minerals required for bacterial growth. Therefore, yeast extract and tryptone were selected as nitrogen sources in this experiment.
[0148] The effects of different yeast extract concentrations on recombinant bacterial biomass and enzyme activity, such as Figure 6 As shown in -b, the cell count essentially reached its maximum at a yeast extract concentration of 20 g / L. Furthermore, the CA enzyme activity reached its highest value of 330.78 U / mL at a yeast extract concentration of 20 g / L; therefore, using a 20 g / L yeast extract concentration is beneficial for CA expression.
[0149] Effects of different tryptone concentrations on recombinant bacterial biomass and enzyme activity, such as Figure 6 As shown in -c, with a fixed yeast extract concentration of 20 g / L, the recombinant bacterial biomass first increased and then decreased with increasing tryptone concentration. CA activity also showed a trend of first increasing and then decreasing with increasing tryptone concentration, reaching a maximum of 405.16 U / mL when the tryptone concentration was 15 g / L. Therefore, 15 g / L tryptone and 20 g / L yeast extract were ultimately selected as the nitrogen source for the culture medium. 2.5.3 Optimization of Phosphate Content in the Culture Medium
[0150] In 50 mL of basal culture medium, the final concentrations of phosphate were set to 40-220 mmol / L, and the results are shown below. Figure 7 .
[0151] Depend on Figure 7It can be seen that the bacterial growth at phosphate concentration of 130 mmol / L is basically the same as at other concentrations, but the enzyme activity reaches its highest level of 326.77 U / mL at this concentration. Therefore, the final phosphate concentration chosen for this experiment was 130 mmol / L.
[0152] 2.5.4 Response Surface Optimization - Establishment of the Mathematical Model for Quadratic Regression Equation and Experimental Results of Variance Analysis and Model Validation
[0153] A response surface methodology-quadratic regression mathematical model was established and subjected to analysis of variance and model validation. The optimization results showed that when the concentrations of glucose, yeast extract, phosphate, and tryptone in the culture medium were 10.33 g / L, 21.80 g / L, 137.63 mmol / L, and 15.60 g / L, respectively, the model predicted a CA enzyme activity of 406.66 U / mL. The corresponding figure is shown in the figure below. Figure 8 .
[0154] Based on the obtained results, equations, and model predictions, and considering operational feasibility, the theoretical optimal conditions of the culture medium were adjusted to: glucose 10.30 g / L, yeast extract 21.80 g / L, phosphate 137.60 mmol / L, and tryptone 15.60 g / L. The optimized culture medium was used to validate the results through three parallel experiments at the shake-flask level. The average CA enzyme activity in the three validation experiments was 401.76 U / mL, with a relative error of 1.14% compared to the maximum enzyme activity predicted by the regression model of 406.66 U / mL.
[0155] 2.6 Effects of CA fermentation induction conditions on enzyme activity
[0156] 2.6.1 Effect of IPTG concentration as an inducer on the growth status and CA enzyme activity of recombinant bacteria
[0157] The effect of IPTG concentration on fermentation is as follows: Figure 9 As shown in -a, when the IPTG concentration increased to 0.2 mmol / L, the CA enzyme activity reached its maximum value of 401.76 U / mL. Therefore, 0.2 mmol / L was selected as the optimal induction concentration.
[0158] 2.6.2 Effect of inoculum size on the growth of recombinant bacteria and CA enzyme activity; results are shown in […]. Figure 9 -b.
[0159] like Figure 9 -b. The inoculum size has no significant effect on the cell volume. At an inoculum size of 4%, CA enzyme activity reaches its maximum after 18 hours of fermentation. When the inoculum size is too large, CA enzyme activity decreases. In summary, the optimal inoculum size is 4%.
[0160] 2.6.3 Effects of fermentation induction temperature and time on the growth status of recombinant bacteria and CA enzyme activity, results are shown in […]. Figure 9-c.
[0161] like Figure 9 -c. Temperature has a significant impact on CA enzyme activity. Both excessively high and low temperatures reduce CA enzyme activity, with a noticeable decrease above 25℃. Therefore, 25℃ was determined to be the optimal fermentation temperature.
[0162] The amount of CA cells in the fermentation broth increased with increasing fermentation time before 18 hours, reaching its peak at 18 hours. After 18 hours, the cell count began to decrease. The results indicate that the optimal fermentation time is 18 hours.
[0163] 2.6.4 Effects of dissolved oxygen concentration on the growth of recombinant bacteria and CA enzyme activity; results are shown in […]. Figure 9 -d.
[0164] like Figure 9 -d, under 40% dissolved oxygen conditions, the cell count reaches its maximum after 14 hours. As time progresses, the cell count gradually decreases. Excessively high dissolved oxygen levels accelerate cell death, possibly due to the toxic effects of excess oxygen or autolysis. When DO is 20%, cell growth is slow. Under 30% dissolved oxygen conditions, enzyme activity reaches its peak at 470.24 U / mL, and the cell count also reaches its maximum after 18 hours. Therefore, fermentation under 30% dissolved oxygen conditions was chosen.
[0165] By optimizing the fermenter culture conditions, it was determined that fermentation culture with 0.2 mmol / L LPTG, 4% inoculum, DO maintained at 30%, and induced at 25℃ for 18 h resulted in CA enzyme activity reaching 470.24 U / mL. Calculations showed that the CA specific enzyme activity reached 367.38 U / mg, which significantly improved CA enzyme activity compared to shake flask culture conditions.
[0166] 2.7 The separation and purification of CA were shown in the figure. Figure 10 .
[0167] Depend on Figure 10 It was found that after specific binding to the AKTAHis Trap HP affinity chromatography column, a single band was obtained near 29 kDa by SDS-PAGE electrophoresis analysis, with the molecular weight consistent with the actual value and a purity ≥95%. The specific enzyme activity after Ni column purification was 687.16 U / mg, while the specific enzyme activity of the crude enzyme solution was 367.38 U / mg, representing a 1.87-fold increase in specific enzyme activity after purification.
[0168] Example 2: Study on heterologous expression and fermentation optimization of creatine kinase CI and sarcosine oxidase SOX
[0169] This invention utilizes the gene sequence of CI from Arthrobacter nicotianae strain 02181 and the gene sequence of SOX from Bacillus sp. to successfully construct recombinant plasmids using genetic engineering methods and achieve soluble expression in E. coli BL21(DE3). The fermentation conditions and enzymatic properties of the recombinant bacteria were studied, and preliminary scale-up production in a 5L fermenter was completed, aiming to provide theoretical basis and technical support for the industrial production of CI and SOX.
[0170] 1. Experimental Materials and Methods
[0171] 1.1 Culture medium and buffer
[0172] Same as step 1.1 in Example 1.
[0173] 1.2 Experimental Methods
[0174] 1.2.1 Plasmid Construction Process
[0175] The gene sequence of CI, derived from *Arthrobacter nicotianae* strain 02181, was obtained from the NCBI gene bank (Genbank: EU004199.2). Using *E. coli* BL21(DE3) as the host strain and pET28a as the expression vector, the codons of the CI gene were optimized for *E. coli*. Subsequently, the codon-optimized CI gene was ligated into the expression vector pET28a at the XhoⅠ and NcoⅠ restriction sites, successfully constructing the recombinant plasmid pET28aHis-CI. The N-terminus of the gene in the recombinant plasmid pET28aHis-CI contains a His-tag. The constructed recombinant plasmid pET28aHis-CI was introduced into *E. coli* competent cells *E. coli* BL21(DE3), and screening was performed on LB agar plates containing kanamycin, finally yielding the positive strain *E. coli* BL21(DE3) (pET28aHis-CI).
[0176] The nucleotide sequence of CI after codon optimization is as follows (SEQ ID NO.3):
[0177]
[0178] Accordingly, the amino acid sequence of CI is (SEQ ID NO.4):
[0179] MGMTTANIATNVSELARLKTLHNGSKQQLTFSDAEFERRLAGLRQIMAAKSLDAVILTSYHGIKYYSDFLYTTFGRNYALVVTQTNSTTVTANIDAGMPWRTSYG ENIVYTDWKRDNFFYGLQEALKRDGVKASRIGVEDDFLPGLTREKIAAAFDGAALVDVSQDAMRQRMIKSAEEIEVIKHGARIGDLGGEAIKAAIREGISEYEVAL IGTEAMVHEIAKTFPHREVRDTWVWFQSGINTDGAHNWATTRKLQRGDILSLNCFPMTSGYYTALERTLFLGEPDARSLELWNVEVHKRGLELIKPGAVCKDIAAELNEIFISHNLLPNRTFGYGHSFGVLSHYYGREAGLELREDIDTVLEPGMVVSMEPMITVADGEPGAGGYREHDILVIGEDGGVENITKFGFGPENNIIDALE.
[0180] The gene sequence of SOX from Bacillus sp. (Genbank No. AY626822.2) was obtained by screening the NCBI gene bank. Using E. coli BL21(DE3) as the host strain and pET28a as the expression vector, the codons of the SOX gene were optimized for E. coli. Subsequently, the codon-optimized SOX gene was ligated into the expression vector pET28a at the XhoⅠ and NcoⅠ restriction sites, successfully constructing the recombinant plasmid pET28a His-SOX. The gene in the recombinant plasmid pET28a His-SOX has a His-tag at the N-terminus. The constructed recombinant plasmid pET28aHis-SOX was introduced into E. coli BL21(DE3) competent cells and screened on LB agar plates containing kanamycin, finally obtaining the positive strain E. coli BL21(DE3)(pET28a His-SOX). The whole-genome synthesis of the gene sequence and the screening of positive strains were completed by Genewiz Biotechnology Co., Ltd.
[0181] The nucleotide sequence of SOX after codon optimization is as follows (SEQ ID NO.5):
[0182]
[0183] Accordingly, the amino acid sequence of SOX is (SEQ ID NO. 6):
[0184] MGMSTHFDVIVVGAGSMGMAAGYYLAKQGVKTLLVDSFDPPHTNGSHHGDTRIIRHAYGEGREYVPFALRAQELWYELEKETHHKIFTQTGVLVFGA KGESDFVAETMEAAKIHSLEHELFEGKQLTERWAGVEVPENYEAIFEPNSGVLFSENCIQAYRELAEAHGAKVLTYAPVEDFEVSEDLVKIQTAKGLY TANKLIVSMGAWNSKLLSKLGVEIPLQPYRQVVAYFECNEEKYSNNVHYPAFMVEVANGIYYGFPSFGGSGLKIGYHTYGQEIDPDTINREFGAYPEDEANLRKFLEKYMPEANGEFKKGAVCMYTKTPDEHFVIDLHPKYSNVVIGAGFSGHGFKFSSAVGETLAQLAVTGKTEHDISIFSLNRDALKKEAAK.
[0185] 1.2.2 Plasmid extraction and double enzyme digestion verification of positive strains
[0186] The operation steps are the same as steps 1.2.2 in Example 1.
[0187] 1.2.3 CI and His-SOX target gene induction expression
[0188] The bacterial strains were the CI and SOX strains after construction, and the operation steps were the same as steps 1, 2, and 3 in Example 1.
[0189] 1.2.4 Preparation of CI and His-SOX crude enzyme solution
[0190] The operation steps are the same as steps 1.2.4 in Example 1.
[0191] 1.2.5 Determination of CI and His-SOX enzyme activity
[0192] 1.2.5.1 Detection principle of CI activity: The substrate creatine is decomposed into urea and sarcosine under the action of creatine enzyme CI. The amino group of urea reacts with the aldehyde group of p-dimethylaminobenzaldehyde (DMAB) to form a new Schiff base structure. The product is an orange-yellow complex, and the absorbance of this complex can be measured at a wavelength of 435 nm.
[0193] (1) Drawing the standard curve of urea
[0194] Prepare urea solutions with gradient concentrations and plot a urea standard curve.
[0195] (2) Detection of CI enzyme activity.
[0196] 1.2.5.2 Principle of SOX Activity Detection: sarcosine is converted into glycine, hydrogen peroxide, and formaldehyde by sarcosine oxidase. Enzyme activity is determined by the Trinder reaction to detect hydrogen peroxide production. Hydrogen peroxide is converted into oxygen by horseradish peroxidase (HRP). The oxygen atom catalyzes the reaction of 4-aminoantipyridine and phenol to produce a purple-red substance with a maximum absorption peak at 500 nm.
[0197] (1) Construction of the standard curve of hydrogen peroxide
[0198] Prepare hydrogen peroxide solutions with gradient concentrations and plot the hydrogen peroxide standard curve.
[0199] (2) Detection of sarcosine oxidase activity.
[0200] 1.2.6 Study on the enzymatic properties of CI and His-SOX
[0201] (1) Optimal temperatures of CI and SOX
[0202] The effects of temperature changes on enzyme activity were determined by using pH 8.0 and temperatures of 20, 30, 40, 50, 60, 70 and 80 °C. The reaction solution with added inactivated enzyme was used as a blank control. The highest enzyme activity was taken as 100%. The ratio of enzyme activity under other temperature conditions to the highest enzyme activity was used as the relative enzyme activity under that temperature condition.
[0203] (2) Determination of thermal stability of CI and SOX
[0204] Take an appropriate amount of enzyme solution and incubate it at 37°C. Measure the remaining enzyme activity at different times, with the initial activity as 100%.
[0205] (3) Optimal pH of Cl and SOX
[0206] The enzyme was incubated at 37°C at pH values of 4.0, 5.0, 6.0, 7.0, 8.0, 9.0, and 10.0 to determine the effect of pH changes on enzyme activity. A reaction solution containing inactivated enzyme was added as a blank control. The highest enzyme activity was taken as 100%, and the ratio of enzyme activity under other pH conditions to the highest enzyme activity was used as the relative enzyme activity under that pH condition.
[0207] (4) Determination of pH stability of CI and SOX
[0208] Take an appropriate amount of enzyme solution and place it in buffer solutions with pH values of 4.0, 5.0, 6.0, 7.0, 8.0, 9.0 and 10.0 respectively. Incubate at 37°C for 24 h and measure the residual enzyme activity after treatment under different pH conditions, with the initial activity as 100%.
[0209] 1.2.7 Optimization of CI and SOX fermentation conditions
[0210] Determination of CI and SOX Escherichia coli LB growth curves: In a sterile laminar flow hood, 10 μL of glycerol bacteria was inoculated into 10 mL of sterilized LB medium and cultured overnight. The next day, 1% inoculum was added to 50 mL of sterilized TB medium. Starting from the inoculation time, samples were taken every hour to detect the OD of the bacterial solution. 600 The data was collected and stopped once it stabilized. The growth curve of the recombinant E. coli was plotted based on the growth status, and the logarithmic growth phase of the strain was analyzed.
[0211] Fermentation time optimization: Fermentation was carried out in a 5L fermenter at induction temperatures of 20, 25 and 30°C respectively. Samples were taken every two hours starting from 4 hours until the end of fermentation at 22 hours, and CI and SOX enzyme activities were measured.
[0212] Optimization of IPTG induction amount and induction temperature: In a 5L fermenter, IPTG was added at final concentrations of 0.2, 0.4, 0.6, 0.8 and 1.0 mmol / L respectively during the induction expression stage, and cultured at three temperatures of 25, 30 and 37℃ respectively. After the fermentation culture was completed, the crude enzyme solution was collected and the activities of CI and SOX were measured.
[0213] Inoculation optimization: In a 5L fermenter, different inoculation amounts of 2%, 4%, 6%, and 8% were selected for inoculation with the seed culture. After fermentation, the crude enzyme solution was collected and the activities of CI and SOX were measured.
[0214] Optimization of dissolved oxygen concentration (DO) during fermentation: In a 5L fermenter, five different dissolved oxygen indices of 20%, 25%, 30%, 35% and 40% were adjusted during fermentation. After fermentation, CI and SOX enzyme activities were measured.
[0215] 1.2.8 Separation and purification of Cl and SOX
[0216] The operation steps are the same as step 1.2.10 in Example 1.
[0217] 2 Results and Discussion
[0218] 2.1 Extraction and enzyme digestion verification of CI and SOX plasmids
[0219] The recombinant plasmids pET28a His-CI and pET28a His-SOX were double-digested with NcoI and XhoI, respectively. The results were then detected by agarose gel electrophoresis and compared with the marker. (See attached table). Figure 11 -a and Figure 11 -b.
[0220] Depend on Figure 11 As can be seen, lane 1 contains the complete pET28a His-CI plasmid, and lane 2 contains two bands with sizes of 5221bp and 1256bp, representing the remaining fragment sizes of the pET28a and CI plasmids, respectively, proving the successful construction of the pET28a His-CI recombinant plasmid. Lane 3 contains the complete pET28a His-SOX plasmid, and lane 4 contains two bands with sizes of 5221bp and 1196bp, representing the remaining fragment sizes of the pET28a and SOX plasmids, respectively, proving the successful construction of the pET28a His-SOX recombinant plasmid.
[0221] 2.2 Induced expression of CI and SOX
[0222] After fermentation, SDS-PAGE electrophoresis was performed, and the results are shown below. Figure 12 .
[0223] Depend on Figure 12 It can be seen that CI and SOX are intracellular enzymes with molecular weights of approximately 47 kDa and 43 kDa, respectively, which is consistent with relevant literature reports, indicating the successful construction of the recombinant strain.
[0224] 2.3 Enzymatic Properties Study of CI and SOX
[0225] 2.3.1 Optimal Temperatures for CI and SOX
[0226] The experimental results for the optimal temperatures of CI and SOX are shown in [reference needed]. Figure 13 .
[0227] like Figure 13 As shown in -a, creatine kinase CI activity reaches its peak at 40℃. At temperatures as high as 70℃, the relative activity of creatine kinase CI is only 36%. Therefore, the optimal temperature for CI is 40℃.
[0228] like Figure 13 As shown in -b, SOX reaches its maximum enzyme activity at 50℃, and only 38% of its maximum enzyme activity at 70℃. Therefore, the optimal temperature for SOX is 50℃.
[0229] 2.3.2 Investigation of the thermal stability of CI and SOX
[0230] The thermal stability of CI and SOX was tested at 37℃ for 30 hours. The results are shown in [Figure number missing]. Figure 14 .
[0231] Depend on Figure 14 It can be seen that CI retains 63.19% of its original activity after incubation at 37℃ for 30 hours, and SOX retains 69.10% of its original activity after incubation at 37℃ for 30 hours, indicating that the two enzymes have good thermostability.
[0232] 2.3.3 Optimal pH for Cl and SOX
[0233] The optimal pH results for CI and SOX are shown in the table below. Figure 15 .
[0234] like Figure 15 As shown in -a, for Cl, the enzyme essentially loses all activity at pH=3. As the ambient pH increases, the enzyme activity gradually increases, reaching its peak at pH=8. Further increasing the pH leads to a decrease in activity. In an alkaline environment at pH=10, the enzyme can still maintain more than 80% of its activity. In summary, the optimal pH for Cl is pH=8.
[0235] like Figure 15 As shown in -b, changes in environmental pH have a significant impact on SOX enzyme activity. As pH increases, SOX enzyme activity shows a trend of first increasing and then decreasing, reaching its highest value at pH=8. After that, as pH continues to increase, enzyme activity shows a decreasing trend. In summary, the optimal pH for SOX is pH=8.
[0236] 2.3.4 Investigation of pH Stability of Cl and SOX
[0237] The results of the CI and SOX pH stability experiments are shown in […]. Figure 16 .
[0238] like Figure 16 As shown in -a, enzymes lose activity more quickly under acidic conditions. For pH ranges of 7.0-8.5, CI can maintain enzyme activity without significant changes. However, as the pH rises above 9.0, the remaining enzyme activity decreases rapidly, and at pH 10.5, only about 30% of the enzyme activity is retained. This indicates that CI is more suitable for use under slightly alkaline conditions (7.0-9.0).
[0239] like Figure 16 As shown in -b, SOX can retain more than 60% of the initial enzyme activity at pH 6.5-8.5, but can only retain less than 30% of the initial enzyme activity at pH 5.5 or greater than 9.5, indicating that SOX is more suitable for use at pH 7.0-8.5.
[0240] 2.4 Effects of CI and SOX fermentation induction conditions on enzyme activity
[0241] 2.4.1 Growth curves and induction timing of CI and SOX recombinant strains are shown in the figure. Figure 17 .
[0242] like Figure 17 As shown in -a, during the growth of strain CI, it enters the logarithmic growth phase 4 hours after inoculation. After 10 hours, the growth rate of the cells slows down. Subsequently, the recombinant strain enters the stationary phase due to nutritional limitations, and the growth rate is basically equal to the cell death rate. Therefore, the inducer is added 4 hours after inoculation.
[0243] like Figure 17 As shown in -b, during the growth of the SOX strain, it enters the logarithmic growth phase 5 hours after inoculation, and the cell growth rate slows down after 12 hours, entering the stationary phase. Therefore, the inducer is added 5 hours after inoculation.
[0244] 2.4.2 Effects of fermentation induction time on the growth status of recombinant bacteria (CI and SOX) and enzyme activity are shown in the figure. Figure 18 .
[0245] like Figure 18 As shown in -a, the enzyme activity of strain CI first increased and then decreased over time, reaching its highest value of 92.02 U / mL 20 hours after the start of fermentation. The cell count also reached its maximum value. The fermentation time of CI was finally set at 20 hours.
[0246] like Figure 18 As shown in -b, during the fermentation of the SOX strain, both enzyme activity and cell mass showed an increasing trend with the extension of induction time. After 21 h of induction, the enzyme activity reached its maximum value of 10.50 U / mL, and the cell biomass also increased to its maximum value. Afterward, with the continuous extension of time, the enzyme activity began to decline, and the E. coli biomass gradually decreased. Therefore, the induction time was ultimately determined to be 21 h. 2.4.3 Effects of fermentation temperature and IPTG concentration on the growth status and enzyme activity of recombinant strains CI and SOX are shown in the figure. Figure 19 .
[0247] like Figure 19 As shown in -a, the final optimized conditions for CI were a fermentation temperature of 30℃ and a final IPTG concentration of 0.4 mmol / L, under which the highest enzyme activity of 125.51 U / mL was achieved.
[0248] like Figure 19 As shown in -b, under the conditions of a final IPTG concentration of 0.6 mmol / L and a temperature of 25 °C, SOX reached its highest enzyme activity of 14.9 U / mL.
[0249] 2.4.4 Effects of inoculum size on the growth status of recombinant bacteria (CI and SOX) and enzyme activity are shown in the figure. Figure 20 .
[0250] like Figure 20 As shown in -a, during the fermentation process, CI reaches its highest enzyme activity of 137.04 U / mL at 4%. The cell count increases with the increase of the inoculum size, and also reaches its peak at 4%. Therefore, 4% is selected as the optimal inoculum size for CI.
[0251] like Figure 20 As shown in -b, the enzyme activity of SOX reached its maximum value of 15.94 U / mL at an inoculum size of 6%, and the bacterial biomass also reached its maximum value at 6%. Therefore, 6% was selected as the optimal inoculum size for SOX.
[0252] 2.4.5 Effects of DO on the growth status of recombinant bacteria in CI and SOX and enzyme activity are shown in the figure. Figure 21 .
[0253] like Figure 21 As shown in -a, when DO is 35%, the enzyme activity produced by the recombinant strain CI is the highest, reaching 149.23 U / mL, and the specific enzyme activity also reaches the highest value of 109.73 U / mg.
[0254] like Figure 21 As shown in -b, at a dissolved oxygen level of 30%, the enzyme activity of the recombinant SOX strain reached a maximum of 18.47 U / mL, with a specific enzyme activity of 13.99 U / mg. The dissolved oxygen level had no significant effect on cell growth; therefore, DO was controlled at 30% during fermentation.
[0255] 2.5Cl and SOX were separated and purified; the results are shown in [Figure number missing]. Figure 22 .
[0256] Depend on Figure 22 As can be seen, the recombinant CI and SOX were analyzed by SDS-PAGE electrophoresis and obtained a single band, which were 47kDa and 43kDa respectively. The molecular weight was consistent with the actual value, and the purity was ≥95%.
[0257] After purification using a Ni column, the specific enzyme activity of the purified CI was 260.06 U / mg, while that of the crude enzyme solution was 109.73 U / mg, representing a 2.37-fold increase in specific enzyme activity after purification. Similarly, the specific enzyme activity of the purified SOX was 27.14 U / mg, while that of the crude enzyme solution was 13.99 U / mg, representing a 1.94-fold increase in specific enzyme activity after purification.
[0258] Example 3: Construction and application of creatinine-degrading enzyme system
[0259] The cascade detection of creatinine oxidase, creatine enzyme, and creatine oxidase is of significant research value in clinical medicine for creatinine detection. This embodiment utilizes the three recombinant enzymes constructed in Examples 1 and 2 to form an enzyme system for detecting creatinine and investigates the effects of various additives on the system's stability.
[0260] 1. Experimental Materials and Methods
[0261] 1.1 Culture medium and buffer
[0262] Same as step 1.1 in Example 1.
[0263] 1.2 Experimental Methods
[0264] 1.2.1 Optimization of enzyme dosage in the three-enzyme detection system
[0265] First, using creatine as a substrate, the reaction of Cl and SOX to generate H2O2 was investigated, and the amount of H2O2 generated was measured. The effect of different amounts of Cl and SOX added on the detection results was examined.
[0266] The specific method is as follows: Take 50 μL of CI and SOX enzyme solutions with the same total enzyme activity and enzyme activity ratios of 1:0.33, 1:0.5, 1:1, 1:2, and 1:3 respectively. Add 3 mL of colorimetric reagent (containing 1 mmol / L 4-aminoantipyrrolidone 4-AAP, 6 mmol / L phenol, 7000 U / L horseradish peroxidase, 20 mmol / L Tris-HCl buffer, pH 8.0), mix well, add 150 μL of anhydrous creatine (0.1 mmol / L), shake to mix, and react in a 37℃ water bath for 5 min. After the reaction is completed, boil in a boiling water bath for 3 min to terminate the reaction. Cool and measure the absorbance at 500 nm to detect the amount of H2O2 generated.
[0267] With the CI and SOX addition ratios fixed, creatinine was detected using the CA, CI, and SOX cascade, and the amount of H2O2 generated was also detected to investigate the effects of the ratio and addition amount of the three enzymes on the detection results.
[0268] The specific method is as follows: Take a total of 50 μL of CA, CI and SOX enzyme solutions with the same total enzyme activity and enzyme activity ratios of 1:4:4, 1:3:3, 1:2:2, 1:1:1, 2:1:1, and 3:1:1, and detect the amount of H2O2 generated according to the above method.
[0269] 1.2.2 Selection of Trinder colorimetric reaction colorants
[0270] In a 20 mmol / L Tris-HCl buffer (pH 8.0), 3.33 U / mL creatinine enzyme, 10 U / mL creatine oxidase, 10 U / mL sarcosine oxidase, 7 U / mL horseradish peroxidase, 0.4 mmol / L 4-AAP, and 0.4 mmol / L Trinder chromogen reagent were added. This reaction mixture was then added to 20 μL of standard creatinine (0.2–8.0 mmol / L) solution and reacted at 37 °C for 120 min. Changes in absorbance at specific wavelengths were then detected. The chromogens selected in the developing solution were TOOS and 3-hydroxy-2,4,6-triiodobenzoic acid, and absorbance changes were detected at 555 nm and 515 nm, respectively. The effects of different chromogen concentrations (0.2, 0.4, and 0.8 mmol / L) on the detection results were also tested.
[0271] 1.2.3 Effect of Protective Agents on the Stability of the Three-Enzyme System
[0272] Mannose, sucrose, maltose, sorbitol, glycerol, DMSO, gelatin, and Tween 20 (final concentration 2 g / L) were thoroughly mixed with an equal volume of CA-CI-SOX enzyme solution and stored at 4°C. The enzyme activity residual rate was measured at 7 days and 14 days.
[0273] Based on the above experiments, the concentration of the selected protective agent was optimized, and the remaining enzyme activity of the system was measured after being stored at 4℃ for 7 days.
[0274] 1.2.4 Proportioning of Composite Protective Agent
[0275] To investigate the effects of composite protectants on enzyme activity, a four-factor, three-level orthogonal experiment was designed based on the results of single-factor optimization to examine the interaction effects of various protectants and determine the optimal ratio of protectants. Table 2 shows the L9(3) enzyme activity. 4 Orthogonal experimental factor level table.
[0276] Table 2. Factor Levels in the Orthogonal Experiment of Composite Protective Agent
[0277]
[0278] 1.2.5 Effects of composite protective agents and preservatives on the storage stability of the test system
[0279] Enzyme solutions with added compound protectant at 4℃ and control group without protectant were stored for a period of time (0, 7, 14, 21 and 28 days). The enzyme activity at storage day 0 was taken as 100%, and the residual enzyme activity of the two groups of enzyme solutions was measured.
[0280] Based on the above experiment, the enzyme solution with 1.0 g / L potassium sorbate preservative was used as the experimental group. At the same time, a control group without protective agent and a group with only compound protective agent were set up. The enzyme solutions were stored at 4℃ for 42 days. The enzyme activity at day 0 was taken as 100%, and the enzyme activity residual rate of the three groups of enzyme solutions was measured.
[0281] 1.3 Three-enzyme cascade detection of creatinine
[0282] 1.3.1 Using one or more of the recombinant CA, CI, and SOX of the present invention, a three-enzyme cascade can be formed with existing commercial enzymes to detect creatinine.
[0283] In a 20 mmol / L Tris-HCl buffer (pH 8.0), add 3.33 U / mL CA, 10 U / mL CI, 10 U / mL LSOX, 7 U / mL horseradish peroxidase, 0.4 mmol / L 4-AAP, and 0.4 mmol / L 3-hydroxy-2,4,6-triiodobenzoic acid. Add 200 μL of this reaction mixture to 20 μL of 2 mmol / L creatinine solution and then to the corresponding wells of a 96-well plate. Incubate at 37°C for 40 min. After the reaction, measure the absorbance of the reaction solution at 515 nm using a microplate reader.
[0284] 1.3.2 Using the recombinant CA, CI, and SOX of this invention, a three-enzyme cascade is constructed for the detection of creatinine.
[0285] Select a series of standard creatinine concentrations (0.200 mmol / L-3.000 mmol / L), and use the same three-enzyme cascade detection method as above. Compare the experimental results with those of commercially available creatinine detection kits.
[0286] 1.4 Creatinine Detection Kit
[0287] The creatinine assay kit of the present invention consists of the following components: CA 3.33 U / mL, CI 10 U / mL, SOX 10 U / mL, horseradish peroxidase 7 U / mL, 4-AAP 0.4 mmol / L, and 3-hydroxy-2,4,6-triiodobenzoic acid 0.4 mmol / L in a 20 mmol / L Tris-HCl buffer system.
[0288] CA, CI, and SOX are prepared according to the optimal method in the embodiments of the present invention.
[0289] A protective agent can also be added to the buffer system. The formula and concentration of the protective agent are as follows: sucrose, sorbitol, Tween 20, and glycerol, with concentrations of 2.0 g / L, 1.5 g / L, 0.5 g / L, and 2.0 g / L, respectively.
[0290] In addition, a preservative can be added, such as potassium sorbate at a concentration of 1.0 g / L.
[0291] 1.4.1 Precision determination
[0292] Precision was determined by measuring the precision seven times consecutively under normal kit calibration conditions, and by testing the precision after no heat treatment and after heat treatment at 37°C for seven days.
[0293] 2 Results and Discussion
[0294] 2.1 Optimization of the amount of each enzyme added in the three-enzyme detection system
[0295] The amount of H2O2 generated was measured under conditions of excess substrate concentration, according to different enzyme solution ratios. Results are shown below. Figure 23 .
[0296] Depend on Figure 23 It was found that the H2O2 production concentration reached its maximum at a CI:SOX ratio of 1:1, with a concentration of 37.82 μmol / L. Based on this, the cascade ratio of the three enzymes was investigated. Under the condition of CA:CI:SOX = 1:3:3, the H2O2 production concentration reached its maximum of 73.47 μmol / L. With excess creatinine as the substrate, the optimal ratio of the three enzymes was 1:3:3.
[0297] 2.2 Optimization of the chromogenic pigment in the creatinine detection system
[0298] 2.2.1 Detection of creatinine using TOOS as a chromogen
[0299] Using TOOS as the color source, the reaction was carried out at 37°C for 120 min. The experimental results are as follows: Figure 24 and Figure 25 .
[0300] Depend on Figure 24 and 25 It can be seen that the absorbance is directly proportional to the detected creatinine concentration, reaching a plateau within 90 min. A good linear relationship is observed in both high (1.0-8.0 mol / L) and low (0.2-0.8 mol / L) creatinine concentration ranges. 2.2.2 Determination of chromogen concentration, results are shown in... Figure 26 .
[0301] Using different concentrations of TOOS as chromogens, the reaction was carried out at pH 8 and 37℃ for 120 min, and the results are as follows. Figure 26 .
[0302] Depend on Figure 26 It can be seen that 0.4 mmol / L is the optimal concentration of chromogen.
[0303] 2.2.3 Detection of creatinine using 3-hydroxy-2,4,6-triiodobenzoic acid as a chromogen
[0304] Using 0.4 mmol / L 3-hydroxy-2,4,6-triiodobenzoic acid as the chromogen, the reaction was carried out at 37 °C for 90 min, and the results were as follows. Figure 27 .
[0305] Depend on Figure 27 It was found that the absorbance was directly proportional to the creatinine concentration, reaching a plateau within 40 minutes. Compared with TOOS, this significantly shortened the detection time. The calibration curve showed good linearity in the low creatinine concentration range (0.1-0.8 mol / L), and the limit of detection was calculated to be 90.75 μM, with the detection time reduced to 40 minutes. Therefore, 0.4 mmol / L 3-hydroxy-2,4,6-triiodobenzoic acid was subsequently used as the chromogen for detection.
[0306] 2.3 Screening of Protective Agent Types
[0307] 2.3.1 The effect of sugar alcohols on enzyme systems; experimental results are shown in […]. Figure 28 -a.
[0308] Depend on Figure 28 -a indicates that after 14 days of storage, sucrose and sorbitol had the highest residual enzyme activity, with the sucrose group having a residual enzyme activity rate of 58.8% and the sorbitol group having a residual enzyme activity rate of 61.0%. Sucrose and sorbitol were selected for subsequent orthogonal experiments.
[0309] 2.3.2 Effects of organic solvents and nonionic surfactants on enzyme systems; experimental results are shown in […]. Figure 28 -b.
[0310] Depend on Figure 28 -b indicates that after 14 days of storage, glycerol and Tween20 showed the highest residual enzyme activity, with the glycerol group having a residual enzyme activity rate of 59.8% and the Tween20 group having a residual enzyme activity rate of 64.0%. Glycerol and Tween20 were selected for subsequent orthogonal experiments.
[0311] 2.3.3 Effect of single protective agent concentration on system stability
[0312] Four different stabilizers—sucrose, sorbitol, Tween 20, and glycerol—were selected to investigate the effects of different concentrations of a single additive on enzyme activity. The results are shown below. Figure 29 .
[0313] Depend on Figure 29It can be seen that 1.5 g / L Tween has the greatest effect on improving the system, and 83.16% of the original enzyme activity can still be retained after 7 days. In addition, the enzyme activity retention rate after 7 days is 74.81% for 1.5 g / L sucrose, 79.63% for 1.0 g / L sorbitol, and 77.45% for 1.0 g / L glycerol. All of these substances can reduce the collision of enzyme molecules in the aqueous environment, making the protein more stable.
[0314] 2.4 Orthogonal Experiment
[0315] The results of the orthogonal experiment are shown in Table 3.
[0316] Table 3. Results of the orthogonal experiment on the composite protective agent
[0317]
[0318] Based on the results in Table 3, the range of values obtained is RB>RA>RC>RD. According to the R value, the order of influence of factors A, B, C, and D on the remaining enzyme activity rate is B>A>C>D. Based on the k value, the optimal ratio can be determined to be A3B3C1D3, that is, 2.0, 1.5, 0.5, and 2.0 g / L of the four additives: sucrose, sorbitol, Tween 20, and glycerol. Under these conditions, three more repeated verification tests were conducted on the composite stabilizer, and the remaining enzyme activity rate was 94.86% after 7 days.
[0319] 2.5 Effects of composite protective agents and preservatives on enzyme activity in the enzyme detection system; experimental results are shown in […]. Figure 30 .
[0320] Depend on Figure 30 As shown in -a, the enzyme activity in the treatment group with added compound protective agent was significantly higher than that in the control group. After 28 days of storage at 4°C, the enzyme activity retention rate in the control group was 19.80%, while the enzyme activity retention rate in the treatment group reached 63.42%.
[0321] Depend on Figure 30 -b indicates that without the addition of protective agents and preservatives, only 13.22% of the initial enzyme activity remained after storage at 4℃ for 42 days; with the addition of a compound protective agent, 59.40% of the initial enzyme activity was retained after storage at 4℃ for 42 days; and with the addition of 1.0 g / L potassium sorbate, the enzyme activity retention rate was 64.98%.
[0322] 3. Enzymatic creatinine detection test
[0323] 3.1 Using one or more of the recombinant CA, CI, and SOX of the present invention, a three-enzyme cascade can be constructed with existing commercial enzymes to detect creatinine.
[0324] The results are shown in Table 4.
[0325] Table 4
[0326]
[0327]
[0328] 3.2 Using the recombinant CA, CI, and SOX of this invention, a three-enzyme cascade is constructed for the detection of creatinine.
[0329] For samples containing different concentrations of creatinine, the three-enzyme cascade detection method in step 1.3 of this embodiment was compared with that of commercially available kits. The results are shown in Table 5. Within the detection range, the relative error was better than that of commercially available kits, indicating that the creatinine detection system designed in this invention has good accuracy.
[0330] Table 5. Determination of creatinine content in samples
[0331]
[0332] 4. Precision determination of the creatinine assay kit
[0333] The results are shown in Table 6. As can be seen from Table 6, the deviations of each value from the standard value are all within 5%.
[0334] Table 6 Precision determination of the creatinine assay kit
[0335]
[0336] Finally, it should be noted that the above descriptions are merely preferred embodiments of the present invention and are not intended to limit the present invention. Although the present invention has been described in detail with reference to the foregoing embodiments, those skilled in the art can still modify the technical solutions described in the foregoing embodiments or make equivalent substitutions for some of the technical features. Any modifications, equivalent substitutions, improvements, etc., made within the spirit and principles of the present invention should be included within the protection scope of the present invention.
Claims
1. A creatinine detection reagent, characterized in that: The creatinine detection reagent includes recombinant creatinine enzyme, recombinant creatine oxidase and recombinant sarcosine oxidase; The amino acid sequence of the recombinant creatinine enzyme is SEQ ID NO.2 in the sequence listing; the amino acid sequence of the recombinant creatine enzyme is SEQ ID NO.4 in the sequence listing; the amino acid sequence of the recombinant sarcosine oxidase is SEQ ID NO.6 in the sequence listing; The nucleotide sequence of the recombinant creatinine enzyme is SEQ ID NO.1 in the sequence listing; the nucleotide sequence of the recombinant creatine enzyme is SEQ ID NO.3 in the sequence listing; the nucleotide sequence of the recombinant sarcosine oxidase is SEQ ID NO.5 in the sequence listing; The preparation methods of the recombinant creatinine enzyme, recombinant creatine oxidase, and recombinant sarcosine oxidase are as follows: (1) SEQ ID NO.1, SEQ ID NO.3 and SEQ ID NO.5 in the sequence listing were respectively constructed into plasmid vectors to obtain three recombinant plasmids; (2) Three recombinant plasmids were transformed into competent Escherichia coli cells to obtain three recombinant Escherichia coli. Recombinant protein expression was induced in each cell, and the cells were broken up and the supernatant was collected. The supernatant was fermented and cultured to obtain crude enzyme solutions of recombinant creatinine enzyme, recombinant creatine enzyme and recombinant sarcosine oxidase, respectively. (3) The three crude enzyme solutions were purified to obtain recombinant creatinine enzyme, recombinant creatine enzyme and recombinant sarcosine oxidase; In step (2), the fermentation culture method of the recombinant creatinine enzyme is as follows: the supernatant of the recombinant creatinine enzyme is inoculated into the culture medium, the IPTG concentration is 0.2 mmol / L, the inoculation amount is 4%, the dissolved oxygen value is controlled at 30%, and the fermentation culture is induced at 25 ℃ for 18 h. The culture medium formulation is as follows: glucose 10.30 g / L, yeast extract 21.80 g / L, phosphate 137.60 mmol / L, and tryptone 15.60 g / L; In step (2), the fermentation culture method of the recombinant creatine enzyme is as follows: the supernatant of the recombinant creatine enzyme is inoculated into the culture medium, and IPTG is added after 4 h of inoculation. The final concentration of IPTG is 0.4 mmol / L, the inoculation amount is 4%, the dissolved oxygen value is controlled at 35%, and fermentation culture is induced at 30℃ for 20 h. The culture medium is TB culture medium; In step (2), the fermentation culture method of the recombinant sarcosine oxidase is as follows: the supernatant of recombinant sarcosine oxidase is inoculated into the culture medium, and IPTG is added after 5 h of inoculation. The final concentration of IPTG is 0.6 mmol / L, the inoculation amount is 6%, the dissolved oxygen value is controlled at 30%, and fermentation culture is induced at 25 ℃ for 21 h. The culture medium is TB culture medium; In step (3), the purification method of the recombinant creatinine enzyme, recombinant creatine oxidase and recombinant sarcosine oxidase is as follows: filter the crude enzyme solution, load the filtrate onto a HisTrap HP affinity column, wash the affinity column with 4% elution buffer until the baseline approaches 0, then elute the recombinant protein with 60% elution buffer, and finally desalt the eluent with a desalting column to obtain purified recombinant creatinine enzyme, recombinant creatine oxidase and recombinant sarcosine oxidase; The elution buffer formulation is: 500 mmol / L imidazole, 20 mmol / L NaH2PO4, 0.5 M NaCl, adjusted to pH 7.4 with HCl; The ratio of the recombinant creatinine enzyme, recombinant creatine oxidase and recombinant sarcosine oxidase is 1:3:
3. The creatinine detection reagent also includes a chromogen, wherein the chromogen is 0.4 mmol / L of 3-hydroxy-2,4,6-triiodobenzoic acid; The creatinine detection reagent also includes a composite protective agent, which is composed of sucrose, sorbitol, Tween 20 and glycerol, and the concentrations of sucrose, sorbitol, Tween 20 and glycerol in the creatinine detection reagent are 2.0 g / L, 1.5 g / L, 0.5 g / L and 2.0 g / L respectively. The creatinine test reagent also includes a preservative, which is potassium sorbate, and the concentration of potassium sorbate in the creatinine test reagent is 1.0 g / L.
2. The use of the creatinine detection reagent according to claim 1 in the preparation of a creatinine detection kit.
Citation Information
Patent Citations
Two-step enzyme measuring method and measuring reagent for creatinine in blood serum
CN102721684A
